Tue, Jun 09 · 8:00

Antibody Engineering and Therapeutics Europe, 9-11 June 2020 in Amsterdam, is the #1 antibody meeting in Europe bringing together world-renowned scientists and academic researchers to deliver the latest science, technologies and partners needed to help you accelerate next generation antibodies towards commercial success.

New Sessions Around 6 Key Themes:
- Potentiating Antibodies through Conjugation
- Bispecific Formats for T Cell Activation
- Cell Engagers for the Innate Immune System
- Advances in Computational and Machine Learning Approaches for Antibody Engineering
- Antibody Discovery and Developability
- Modifying Fc Interactions to Enhance Antibody Therapies

Visit: AntibodyEngEu.com

Industry - Conference Only (until 13 March): GBP 1599.0,
Academic - Conference Only (until 13 March): GBP 649.0,
Industry - Conference Only (until 17 April): GBP 1699.0,
Academic - Conference Only (until 17 April): GBP 699.0,
Industry - Conference Only (Standard Rate): GBP 1799.0,
Academic - Conference Only (Standard Rate): GBP 749.0

Speakers: Serge Muyldermans, Ph.D. Professor, Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Belgium, Jannie Borst, Ph.D., Head, Department of Immunohematology and Blood Transfusion, Leiden University Medical School, The Netherlands, Jeanette L. Leusen, Ph.D. Associate Professor, Head Immunotherapy Group and UMAB Facility, Laboratory for Translational Immunology, University Medical Center Utrecht, The Netherlands, Sergio Quezada, Ph.D. Professorial Research Fellow, Immune Regulation and Tumor Immunotherapy Group, UCL Cancer Institute, United Kingdom